| Financial Year |
March 31 2023 |
| Monetary Funds |
347,336,682.51 |
| Held-for-trading Financial Assets |
21,174,904.11 |
| Notes Receivable |
14,786,481.45 |
| Accounts Receivable |
146,457,412.70 |
| Advances to Suppliers |
11,653,618.11 |
| Other Receivables |
1,039,544.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
167,381,664.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,523,545.36 |
| Total Current Assets |
820,357,923.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,331,459.34 |
| Investment Properties |
27,632,751.64 |
| Fixed Assetes |
17,109,931.56 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,210,911.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
138,920.58 |
| Deferred Income Tax Assets |
21,465,683.58 |
| Other Non-Current Assets |
10,698.22 |
| Sub-Total of Non-Current Assets |
131,398,254.73 |
| Total Assets |
951,756,178.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
83,908,968.62 |
| Accounts Payable |
61,722,675.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,045,848.44 |
| Taxes Payable |
3,165,161.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,410,922.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,437,773.11 |
| Other Current Liabilities |
44,567,235.05 |
| Sub-Total of Current Liabilities |
250,277,364.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
176,235.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,346,115.36 |
| Total Liabilities |
252,623,480.18 |
| Paid-In Capital(Or Share Stock) |
208,615,900.00 |
| Capital Surplus |
84,693,889.57 |
| Surplus Reserve |
71,368,718.39 |
| LESS:Treasury Stock |
12,921,960.00 |
| Undistributed Profits |
335,540,695.01 |
| Minority Stockholder's Interest |
11,835,455.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
687,297,242.97 |
| Owner's Equity（Stockholder's Equity） |
699,132,698.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
951,756,178.18 |
